Question 1

Does IMC-Chicago own MRNA stock?

Accepted Answer

No. IMC-Chicago exited its MRNA (Moderna) position in Q1 2026. Its Q4 2025 13F listed 257,166 shares worth $7.6M.

Question 2

How many shares of MRNA does IMC-Chicago own?

Accepted Answer

None since Q1 2026, when IMC-Chicago exited the position. Its Q4 2025 13F listed 257,166 shares worth $7.6M.

Question 3

What is IMC-Chicago's MRNA position worth?

Accepted Answer

IMC-Chicago's MRNA position was worth $7.6M in its Q4 2025 13F, before the exit in Q1 2026.

Question 4

Is IMC-Chicago buying or selling MRNA?

Accepted Answer

In Q1 2026, IMC-Chicago exited its entire MRNA position.

Question 5

When did IMC-Chicago first buy MRNA?

Accepted Answer

IMC-Chicago first reported MRNA in its Q2 2020 13F and listed it in 11 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q1 Latest	Exited	0	-100.0%	$0	0.0%	$49.83	0
2025-Q4	Decreased	257,166	-39.5%	$7.6M	0.0%	$30.41	0
2025-Q3	Decreased	424,687	-3.2%	$11M	0.0%	$25.33	0
2025-Q2	Decreased	438,683	-10.9%	$12.1M	0.0%	$27.16	0
2025-Q1	New	492,257	—	$14M	0.0%	$31.12	39
2024-Q4	Exited	0	-100.0%	$0	0.0%	$39.38	0
2024-Q3	Decreased	26,611	-65.4%	$1.8M	0.0%	$65.75	0